These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34665803)

  • 1. High SARS-CoV-2 seroprevalence in persons experiencing homelessness and shelter workers from a day-shelter in São Paulo, Brazil.
    do Couto AC; Kmetiuk LB; Delai RR; Brandão APD; Monteiro CO; da Silva LHA; Soares C; Banari AC; Bach RVW; Pettan-Brewer C; Dos Santos AP; Guimarães AMS; Oliveira DBL; Durigon EL; Biondo AW
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009754. PubMed ID: 34665803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 antibodies among homeless people living rough, in shelters and squats: A large population-based study in France.
    Loubiere S; Monfardini E; Allaria C; Mosnier M; Allibert A; Ninove L; Bosetti T; Farnarier C; Hamouda I; Auquier P; Mosnier E; Tinland A
    PLoS One; 2021; 16(9):e0255498. PubMed ID: 34525096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 antibody prevalence among homeless people and shelter workers in Denmark: a nationwide cross-sectional study.
    Eriksen ARR; Fogh K; Hasselbalch RB; Bundgaard H; Nielsen SD; Jørgensen CS; Scharff BFSS; Erikstrup C; Sækmose SG; Holm DK; Aagaard B; Kristensen JH; Bødker CA; Norsk JB; Nielsen PB; Østergaard L; Ellermann-Eriksen S; Andersen B; Nielsen H; Johansen IS; Wiese L; Simonsen L; K Fischer T; Folke F; Lippert F; Ostrowski SR; Ethelberg S; Koch A; Vangsted AM; Krause T; Fomsgaard A; Nielsen C; Ullum H; Skov R; Iversen K
    BMC Public Health; 2022 Jun; 22(1):1261. PubMed ID: 35761270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serosurvey of
    Kmetiuk LB; Gonçalves G; Chechia Do Couto A; Biondo AW; Figueiredo FB
    Front Public Health; 2023; 11():1125028. PubMed ID: 36935667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serosurvey of anti-Toxocara canis antibodies in people experiencing homelessness and shelter workers from São Paulo, Brazil.
    Santarém VA; do Couto AC; Lescano SZ; Roldán WH; Delai RR; Giuffrida R; Kmetiuk LB; Biondo AW; Dangoudoubiyam S; Dos Santos AP
    Parasit Vectors; 2022 Oct; 15(1):373. PubMed ID: 36253837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of three point-of-care lateral flow immunoassays for detection of anti-SARS-CoV-2 antibodies: data from 100 healthcare workers in Brazil.
    Conte DD; Carvalho JMA; de Souza Luna LK; Faíco-Filho KS; Perosa AH; Bellei N
    Braz J Microbiol; 2021 Sep; 52(3):1161-1165. PubMed ID: 33871824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.
    Meireles P; Amaro J; Pinto da Costa J; Lopes MM; Varandas T; Norton P; Guimarães JT; Severo M; Barros H
    Occup Environ Med; 2021 Sep; 78(9):648-653. PubMed ID: 34193594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological Screening for Antibodies against SARS-CoV-2 in Dutch Shelter Cats.
    van der Leij WJR; Broens EM; Hesselink JW; Schuurman N; Vernooij JCM; Egberink HF
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.
    Batchi-Bouyou AL; Lobaloba Ingoba L; Ndounga M; Vouvoungui JC; Mfoutou Mapanguy CC; Boumpoutou KR; Ntoumi F
    Int J Infect Dis; 2021 May; 106():3-7. PubMed ID: 33370565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serosurvey of Anti-
    Felipetto LG; Teider-Junior PI; da Silva FFV; Yamakawa AC; Kmetiuk LB; do Couto AC; Martins CM; Vaz ES; Ullmann LS; Langoni H; Timenetsky J; Dos Santos AP; Biondo AW
    Front Public Health; 2020; 8():580637. PubMed ID: 33251175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.
    Fisher M; Levy H; Fatelevich E; Afrimov Y; Ben-Shmuel A; Rosenfeld R; Noy-Porat T; Glinert I; Sittner A; Biber A; Belkin A; Bar-David E; Puni R; Levy I; Mazor O; Weiss S; Mechaly A
    Microbiol Spectr; 2021 Oct; 9(2):e0087021. PubMed ID: 34612689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
    Tönshoff B; Müller B; Elling R; Renk H; Meissner P; Hengel H; Garbade SF; Kieser M; Jeltsch K; Grulich-Henn J; Euler J; Stich M; Chobanyan-Jürgens K; Zernickel M; Janda A; Wölfle L; Stamminger T; Iftner T; Ganzenmueller T; Schmitt C; Görne T; Laketa V; Olberg S; Plaszczyca A; Cortese M; Bartenschlager R; Pape C; Remme R; Huzly D; Panning M; Weigang S; Giese S; Ciminski K; Ankerhold J; Kochs G; Schwemmle M; Handgretinger R; Niemeyer CM; Engel C; Kern WV; Hoffmann GF; Franz AR; Henneke P; Debatin KM; Kräusslich HG
    JAMA Pediatr; 2021 Jun; 175(6):586-593. PubMed ID: 33480966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection.
    Kučinskaitė-Kodzė I; Simanavičius M; Šimaitis A; Žvirblienė A
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France.
    Gégout Petit A; Jeulin H; Legrand K; Jay N; Bochnakian A; Vallois P; Schvoerer E; Guillemin F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serosurvey of anti-treponema pallidum (syphilis), anti-hepatitis C virus and anti-HIV antibodies in homeless persons of São Paulo city, southeastern Brazil.
    Felipetto LG; Teider-Junior PI; da Silva FFV; Couto ACD; Kmetiuk LB; Martins CM; Ullmann LS; Timenetsky J; Santos APD; Biondo AW
    Braz J Infect Dis; 2021; 25(4):101602. PubMed ID: 34389284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
    Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
    BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.